- Home
- MRVI vs GAU Comparison
MRVI vs GAU Comparison
Compare MRVI & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- GAU
- Stock Information
- Founded
- MRVI 2014
- GAU 1999
- Country
- MRVI United States
- GAU Canada
- Employees
- MRVI N/A
- GAU N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- GAU
- Sector
- MRVI Health Care
- GAU
- Exchange
- MRVI Nasdaq
- GAU Nasdaq
- Market Cap
- MRVI 371.8M
- GAU 408.3M
- IPO Year
- MRVI 2020
- GAU N/A
- Fundamental
- Price
- MRVI $2.42
- GAU $2.16
- Analyst Decision
- MRVI Hold
- GAU Strong Buy
- Analyst Count
- MRVI 10
- GAU 2
- Target Price
- MRVI $5.84
- GAU $3.00
- AVG Volume (30 Days)
- MRVI 1.4M
- GAU 2.7M
- Earning Date
- MRVI 08-11-2025
- GAU 08-13-2025
- Dividend Yield
- MRVI N/A
- GAU N/A
- EPS Growth
- MRVI N/A
- GAU N/A
- EPS
- MRVI N/A
- GAU N/A
- Revenue
- MRVI $219,830,000.00
- GAU $309,575,000.00
- Revenue This Year
- MRVI N/A
- GAU $80.61
- Revenue Next Year
- MRVI $7.23
- GAU $43.30
- P/E Ratio
- MRVI N/A
- GAU N/A
- Revenue Growth
- MRVI N/A
- GAU 223.63
- 52 Week Low
- MRVI $1.67
- GAU $1.00
- 52 Week High
- MRVI $9.60
- GAU $2.19
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- GAU 77.92
- Support Level
- MRVI $2.28
- GAU $2.09
- Resistance Level
- MRVI $2.47
- GAU $2.16
- Average True Range (ATR)
- MRVI 0.14
- GAU 0.10
- MACD
- MRVI -0.01
- GAU 0.02
- Stochastic Oscillator
- MRVI 27.45
- GAU 97.64
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.